title: [Phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: past, present and future].
abstract: This review article describes the differences in efficacy and side effects between available phosphodiesterase type 5 (PDE-5) inhibitors used for treating erectile dysfunction. The most studied PDE-5 inhibitor is sildenafil.
authors.affiliation: Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
authors.forename: S I
authors.initials: SI
authors.lastname: Gamidov
authors.affiliation: Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
authors.forename: R I
authors.initials: RI
authors.lastname: Ovchinnikov
authors.affiliation: Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
authors.forename: A Yu
authors.initials: AY
authors.lastname: Popova
authors.affiliation: Department of Andrology and Urology, V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia, Moscow, Russia.
authors.forename: S Kh
authors.initials: SK
authors.lastname: Izhbaev
mesh_terms: D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D000068677:Sildenafil Citrate / Q000627:therapeutic use; D000068581:Tadalafil / Q000627:therapeutic use; D000069058:Vardenafil Dihydrochloride / Q000627:therapeutic use
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D000069058:Vardenafil Dihydrochloride; D000068581:Tadalafil; D000068677:Sildenafil Citrate
keywords: erectile dysfunction; phosphodiesterase type 5 inhibitors; safety; sildenafil; tadalafil; vardenafil